keyword
https://read.qxmd.com/read/38745338/correlating-reiff-scores-with-clinical-functional-and-prognostic-factors-characterizing-noncystic-fibrosis-bronchiectasis-severity-validation-from-a-nationwide-multicenter-study-in-taiwan
#21
MULTICENTER STUDY
Wen-Chien Cheng, Chia-Ling Chang, Chau-Chyun Sheu, Ping-Huai Wang, Meng-Heng Hsieh, Ming-Tsung Chen, Wei-Fan Ou, Yu-Feng Wei, Tsung-Ming Yang, Chou-Chin Lan, Cheng-Yi Wang, Chih-Bin Lin, Ming-Shian Lin, Yao-Tung Wang, Ching-Hsiung Lin, Shih-Feng Liu, Meng-Hsuan Cheng, Yen-Fu Chen, Chung-Kan Peng, Ming-Cheng Chan, Ching-Yi Chen, Lun-Yu Jao, Ya-Hui Wang, Chi-Jui Chen, Shih-Pin Chen, Yi-Hsuan Tsai, Shih-Lung Cheng, Horng-Chyuan Lin, Jung-Yien Chien, Hao-Chien Wang, Wu-Huei Hsu
BACKGROUND: Our study aimed to confirm a simplified radiological scoring system, derived from a modified Reiff score, to evaluate its relationship with clinical symptoms and predictive outcomes in Taiwanese patients with noncystic fibrosis bronchiectasis (NCFB). METHODS: This extensive multicenter retrospective study, performed in Taiwan, concentrated on patients diagnosed with NCFB verified through high-resolution computed tomography (HRCT) scans. We not only compared the clinical features of various types of bronchiectasis (cylindrical, varicose, and cystic)...
May 14, 2024: European Journal of Medical Research
https://read.qxmd.com/read/38744964/analysis-of-alphamissense-data-in-different-protein-groups-and-structural-context
#22
JOURNAL ARTICLE
Hedvig Tordai, Odalys Torres, Máté Csepi, Rita Padányi, Gergely L Lukács, Tamás Hegedűs
Single amino acid substitutions can profoundly affect protein folding, dynamics, and function. The ability to discern between benign and pathogenic substitutions is pivotal for therapeutic interventions and research directions. Given the limitations in experimental examination of these variants, AlphaMissense has emerged as a promising predictor of the pathogenicity of missense variants. Since heterogenous performance on different types of proteins can be expected, we assessed the efficacy of AlphaMissense across several protein groups (e...
May 14, 2024: Scientific Data
https://read.qxmd.com/read/38744777/distribution-of-pathogenic-variants-in-the-cftr-gene-in-a-representative-cohort-of-people-with-cystic-fibrosis-in-the-kingdom-of-bahrain
#23
JOURNAL ARTICLE
Osama A Karim Majed, Fatema Osama Majed, Nabeel Jasim Almoamen, Husain Baqer Alsatrawi, Salma Dawood Shehabi, Jana Hrbková, Malgorzata Libik, Milan Macek
BACKGROUND: Cystic fibrosis (CF) is a rare multi-systemic recessive disorder. The spectrum and the frequencies of CFTR mutations causing CF vary amongst different populations in Europe and the Middle East. In this study, we characterised the distribution of CF-causing mutations (i.e. pathogenic variants in the  CFTR gene) in a representative CF cohort from the Kingdom of Bahrain based on a three-decade-long analysis at a single tertiary centre. We aim to improve CF genetic diagnostics, introduce of CF neonatal screening and provide CFTR modulator therapy (CFTRm)...
May 14, 2024: Molecular Genetics and Genomics: MGG
https://read.qxmd.com/read/38743489/arteriovenous-metabolomics-in-pigs-reveals-cftr-regulation-ofmetabolism-inmultiple-organs
#24
JOURNAL ARTICLE
Hosung Bae, Bo Ram Kim, Sunhee Jung, Johnny Le, Dana M van der Heide, Wenjie Yu, Sang Hee Park, Brieanna M Hilkin, Nicholas D Gansemer, Linda S Powers, Taekyung Kang, David K Meyerholz, Victor L Schuster, Cholsoon Jang, Michael J Welsh
Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene cause cystic fibrosis (CF), a multiorgan disease that exhibits diverse metabolic defects. However, other than specific CFTR mutations, the factors that influence disease progression and severity remain poorly understood. Aberrant metabolite levels have been reported, but whether CFTR loss itself or secondary abnormalities (infection, inflammation, malnutrition, and various treatments) drive metabolic defects are uncertain. Here, we implemented comprehensive arteriovenous metabolomics in newborn CF pigs, and the results revealed CFTR as a bona fide regulator of metabolism...
May 14, 2024: Journal of Clinical Investigation
https://read.qxmd.com/read/38742824/synergistic-effects-of-sulopenem-in-combination-with-cefuroxime-or-durlobactam-against-mycobacterium-abscessus
#25
JOURNAL ARTICLE
Khalid M Dousa, Eunjeong Shin, Sebastian G Kurz, Mark Plummer, Mary Nantongo, Christopher R Bethel, Magdalena A Taracila, David C Nguyen, Barry N Kreiswith, Charles L Daley, Kenneth E Remy, Steven M Holland, Robert A Bonomo
UNLABELLED: Mycobacterium abscessus ( Mab ) affects patients with immunosuppression or underlying structural lung diseases such as cystic fibrosis (CF). Additionally, Mab poses clinical challenges due to its resistance to multiple antibiotics. Herein, we investigated the synergistic effect of dual β-lactams [sulopenem and cefuroxime (CXM)] or the combination of sulopenem and CXM with β-lactamase inhibitors [BLIs-avibactam (AVI) or durlobactam (DUR)]. The sulopenem-CXM combination yielded low minimum inhibitory concentration (MIC) values for 54 clinical Mab isolates and ATCC19977 (MIC50 and MIC90 ≤0...
May 14, 2024: MBio
https://read.qxmd.com/read/38742742/unlocking-the-genetic-tapestry-of-autoimmune-diseases-unveiling-common-genes-across-multiple-conditions
#26
JOURNAL ARTICLE
Soujanya Ghosh, Rupali Mohanty, Arunava Santra, Anisha Saha, Anubha Agrawal, Sharmishtha Shrivastava, Chandrashish Roy, Ishanee Mazumder, Debarup Das, Syed Haaris Mahmood
OBJECTIVES: This study aimed to unravel the complexities of autoimmune diseases by conducting a comprehensive analysis of gene expression data across 10 conditions, including systemic lupus erythematosus (SLE), psoriasis, Sjögren's syndrome, sclerosis, immune-associated diseases, osteoarthritis, cystic fibrosis, inflammatory bowel disease (IBD), type 1 diabetes, and Guillain-Barré syndrome. METHODS: Gene expression profiles were rigorously examined to identify both upregulated and downregulated genes specific to each autoimmune disease...
May 2024: International Journal of Rheumatic Diseases
https://read.qxmd.com/read/38742380/-italian-cystic-fibrosis-registry-icfr-report-2021-2022
#27
JOURNAL ARTICLE
Giuseppe Campagna, Annalisa Amato, Fabio Majo, Gianluca Ferrari, Serena Quattrucci, Rita Padoan, Giovanna Floridia, Donatello Salvatore, Vincenzo Carnovale, Gianna Puppo Fornaro, Domenica Taruscio, Marco Salvatore
INTRODUCTION: Italian Cystic Fibrosis Registry (ICFR) collects data of patients with cystic fibrosis (CF) through the collaboration with Italian CF referral and support Centres (Italian law 548/93). It aims at analysing medium and long-term clinical and epidemiological trends, identifying healthcare needs at regional and national levels, contributing to healthcare programmes, and resource allocation. Italian data are also compared at international level through the collaboration with the European CF Registry for sharing epidemiological data on general aspects like CF epidemiology and specific topics such as the use of CFTR modulators...
2024: Epidemiologia e Prevenzione
https://read.qxmd.com/read/38742326/a-first-experience-of-distant-lung-preservation-for-transplantation-in-the-russian-federation
#28
JOURNAL ARTICLE
Evgeny A Tarabrin, Artem A Saprin, Taimuraz E Kallagov, Sergey Y Pushkin, Ekaterina Y Anosova, Boris I Yaremin
Lung transplant is an effective method of treating patients with end-stage respiratory diseases, but problems such as the imbalance between the number of donor organs and the number ofrecipients needing organs still play a leading role. From a transplant point of view, a multiorgan donor is considered of greatest efficiency, so that all organs that can potentially be used should be transplanted. The combination of the vast geographical territory of Russia, the shortage of actual donors, and the relatively small number of transplant centers has led to the need to transport donor lungs by air over long distances...
April 2024: Experimental and Clinical Transplantation
https://read.qxmd.com/read/38742253/obstructive-sleep-apnea-in-children-with-cystic-fibrosis-on-highly-effective-modulator-therapy
#29
JOURNAL ARTICLE
Aarti Shakkottai, Stephany Kim, Ron B Mitchell
INTRODUCTION: Obstructive sleep apnea (OSA) is common in children with cystic fibrosis (CF). Highly effective modulator therapies (HEMT) have led to improved sinopulmonary disease, but whether this translates to a lower frequency of OSA is unknown. METHODS: We conducted a single center retrospective review of polysomnographic (PSG) data from 2012 to 2023 in patients aged 0-18 years with CF to assess frequency of OSA. Participants were classified based on HEMT status...
May 14, 2024: Pediatric Pulmonology
https://read.qxmd.com/read/38738679/chronic-jejuno-colonic-fistula-and-intestinal-malabsorption-due-to-multiple-magnet-ingestions-a-case-report-and-systematic-review
#30
REVIEW
Rahşan Özcan, Ali Ekber Hakalmaz, Ayşe Kalyoncu Uçar, Omer Beser, Senol Emre
Magnet ingestion in children can lead to serious complications, both acutely and chronically. This case report discusses the treatment approach for a case involving multiple magnet ingestions, which resulted in a jejuno-colonic fistula, segmental intestinal volvulus, hepa-tosteatosis, and renal calculus detected at a late stage. Additionally, we conducted a literature review to explore the characteristics of intestinal fistulas caused by magnet ingestion. A six-year-old girl was admitted to the Pediatric Gastroenterology Department pre-senting with intermittent abdominal pain, vomiting, and diarrhea persisting for two years...
May 2024: Turkish Journal of Trauma & Emergency Surgery: TJTES
https://read.qxmd.com/read/38737802/challenging-fungal-infections-in-cystic-fibrosis-a-case-of-mixed-aspergillus-species-infection-and-antifungal-combination-testing
#31
Laís Pontes, Franqueline Reichert-Lima, Ana Luisa Perini Leme Giordano, Maria Luiza Moretti, Angélica Zaninelli Schreiber
Aspergillus stands as the predominant fungal genus in the airways of cystic fibrosis (CF) patients, significantly contributing to their morbidity and mortality. Aspergillus fumigatus represents the primary causative species for infections, though the emergence of rare species within the Aspergillus section Fumigati has become noteworthy. Among these, Aspergillus lentulus is particularly significant due to its frequent misidentification and intrinsic resistance to azole antifungal agents. In the management of invasive aspergillosis and resistant infections, combination antifungal therapy has proven to be an effective approach...
2024: Access microbiology
https://read.qxmd.com/read/38737127/airway-basal-cells-from-human-induced-pluripotent-stem-cells-a-new-frontier-in-cystic-fibrosis-research
#32
JOURNAL ARTICLE
Anna Demchenko, Lyubava Belova, Maxim Balyasin, Konstantin Kochergin-Nikitsky, Ekaterina Kondrateva, Ekaterina Voronina, Victoria Pozhitnova, Vyacheslav Tabakov, Diana Salikhova, Tatiana Bukharova, Dmitry Goldshtein, Elena Kondratyeva, Tatiana Kyian, Elena Amelina, Olga Zubkova, Olga Popova, Tatiana Ozharovskaia, Alexander Lavrov, Svetlana Smirnikhina
Human-induced airway basal cells (hiBCs) derived from human-induced pluripotent stem cells (hiPSCs) offer a promising cell model for studying lung diseases, regenerative medicine, and developing new gene therapy methods. We analyzed existing differentiation protocols and proposed our own protocol for obtaining hiBCs, which involves step-by-step differentiation of hiPSCs into definitive endoderm, anterior foregut endoderm, NKX2.1+ lung progenitors, and cultivation on basal cell medium with subsequent cell sorting using the surface marker CD271 (NGFR)...
2024: Frontiers in Cell and Developmental Biology
https://read.qxmd.com/read/38735372/maternal-and-fetal-outcomes-in-multiparous-women-with-cystic-fibrosis
#33
JOURNAL ARTICLE
Malena Cohen-Cymberknoh, Maya Ariel Dabby, Bar Gindi Reiss, Joel Melo Tanner, Gema Pérez, Noah Lechtzin, Eva Polverino, Javier Pérez Miranda, Andrea Gramegna, Stefano Aliberti, Hagit Levine, Huda Mussaffi, Hanna Blau, Dario Prais, Meir Mei-Zahav, Michal Shteinberg, Galit Livnat, Michal Gur, Lea Bentur, Damian G Downey, Adi Dagan, Inbal Golan-Tripto, Micha Aviram, Pedro Mondejar-Lopez, Elie Picard, Carsten Schwarz, Petr Jakubec, Traci M Kazmerski, Hagai Amsalem, Drorit Hochner Celnikier, Eitan Kerem, Joel Reiter
BACKGROUND: Quality of life and survival in Cystic Fibrosis (CF) have improved dramatically, making family planning a feasible option. Maternal and perinatal outcomes in women with CF (wwCF) are similar to those seen in the general population. However, the effect of undergoing multiple pregnancies is unknown. METHODS: A multinational-multicenter retrospective cohort study. Data was obtained from 18 centers worldwide, anonymously, on wwCF 18-45 years old, including isease severity and outcome, as well as obstetric and newborn complications...
May 10, 2024: Respiratory Medicine
https://read.qxmd.com/read/38734793/exploring-the-dynamics-of-mixed-species-biofilms-involving-candida-spp-and-bacteria-in-cystic-fibrosis
#34
REVIEW
Karima Gourari-Bouzouina, Zahia Boucherit-Otmani, Noureddine Halla, Abdelfettah Seghir, Zahira Zakia Baba Ahmed-Kazi Tani, Kebir Boucherit
Cystic fibrosis (CF) is an inherited disease that results from mutations in the gene responsible for the cystic fibrosis transmembrane conductance regulator (CFTR). The airways become clogged with thick, viscous mucus that traps microbes in respiratory tracts, facilitating colonization, inflammation and infection. CF is recognized as a biofilm-associated disease, it is commonly polymicrobial and can develop in biofilms. This review discusses Candida spp. and both Gram-positive and Gram-negative bacterial biofilms that affect the airways and cause pulmonary infections in the CF context, with a particular focus on mixed-species biofilms...
May 11, 2024: Archives of Microbiology
https://read.qxmd.com/read/38734509/the-clinical-utility-of-sequencing-the-entirety-of-cftr
#35
JOURNAL ARTICLE
Molly B Sheridan, Melis A Aksit, Kymberleigh Pagel, Kurt Hetrick, Hannah Shultz-Lutwyche, Ben Myers, Kati J Buckingham, Rhonda G Pace, Hua Ling, Elizabeth Pugh, Wanda K O'Neal, Michael J Bamshad, Ronald L Gibson, Michael R Knowles, Scott M Blackman, Garry R Cutting, Karen S Raraigh
BACKGROUND: Cystic fibrosis (CF) is caused by deleterious variants in each CFTR gene. We investigated the utility of whole-gene CFTR sequencing when fewer than two pathogenic or likely pathogenic (P/LP) variants were detected by conventional testing (sequencing of exons and flanking introns) of CFTR. METHODS: Individuals with features of CF and a CF-diagnostic sweat chloride concentration with zero or one P/LP variants identified by conventional testing enrolled in the CF Mutation Analysis Program (MAP) underwent whole-gene CFTR sequencing...
May 10, 2024: Journal of Cystic Fibrosis: Official Journal of the European Cystic Fibrosis Society
https://read.qxmd.com/read/38734430/insights-and-considerations-on-cftr-variant-reporting-in-a-study-of-cystic-fibrosis-patients-in-saudi-arabia-cftr-1548del-g-and-1549del-g-navigating-the-discovery-of-novel-mutations
#36
JOURNAL ARTICLE
https://read.qxmd.com/read/38734153/association-between-bronchiectasis-exacerbations-and-longitudinal-changes-in-fev-1-in-patients-from-the-us-bronchiectasis-and-ntm-research-registry
#37
JOURNAL ARTICLE
Timothy R Aksamit, Nicole C Lapinel, Radmila Choate, Joseph Feliciano, Kevin L Winthrop, Andreas Schmid, Jasmanda Wu, Sebastian Fucile, Mark L Metersky
BACKGROUND: This study aimed to evaluate the association between the number of non-cystic fibrosis bronchiectasis (bronchiectasis) exacerbations during baseline and follow-up (objective 1) and to identify longitudinal changes in FEV1 associated with exacerbation frequency (objective 2). METHODS: This was a retrospective cohort study of adult patients enrolled in the US Bronchiectasis and Nontuberculous Mycobacteria Research Registry September 2008 to March 2020...
May 9, 2024: Respiratory Medicine
https://read.qxmd.com/read/38732584/vitamin-k-status-based-on-k1-mk-4-mk-7-and-undercarboxylated-prothrombin-levels-in-adolescent-and-adult-patients-with-cystic-fibrosis-a-cross-sectional-study
#38
JOURNAL ARTICLE
Patrycja Krzyżanowska-Jankowska, Jan Nowak, Marta Karaźniewicz-Łada, Małgorzata Jamka, Eva Klapkova, Szymon Kurek, Sławomira Drzymała-Czyż, Aleksandra Lisowska, Irena Wojsyk-Banaszak, Wojciech Skorupa, Jarosław Szydłowski, Richard Prusa, Jarosław Walkowiak
The available evidence on vitamin K status in cystic fibrosis (CF) is scarce, lacking data on vitamin K2 (menaquinones-MK). Therefore, we assessed vitamin K1, MK-4 and MK-7 concentrations (LC-MS/MS) in 63 pancreatic insufficient and modulator naïve CF patients, and compared to 61 healthy subjects (HS). Vitamin K1 levels did not differ between studied groups. MK-4 concentrations were higher (median <1st-3rd quartile>: 0.778 <0.589-1.086> vs. 0.349 <0.256-0.469>, p < 0.0001) and MK-7 levels lower (0...
April 29, 2024: Nutrients
https://read.qxmd.com/read/38731582/antibiofilm-activity-of-combretum-micranthum-g-don-catechin-sugar-phytocomplex-on-pseudomonas-aeruginosa
#39
JOURNAL ARTICLE
Viviana Teresa Orlandi, Fabrizio Bolognese, Luca Chiodaroli, Ilaria Armenia, Enrico Caruso, Miryam Chiara Malacarne
Clinicians often have to face infections caused by microorganisms that are difficult to eradicate due to their resistance and/or tolerance to antimicrobials. Among these pathogens, Pseudomonas aeruginosa causes chronic infections due to its ability to form biofilms on medical devices, skin wounds, ulcers and the lungs of patients with Cystic Fibrosis. In this scenario, the plant world represents an important reservoir of natural compounds with antimicrobial and/or antibiofilm properties. In this study, an extract from the leaves of Combretum micranthum G...
May 1, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/38731170/evaluation-of-target-attainment-for-tobramycin-in-children-and-adults-with-cystic-fibrosis
#40
JOURNAL ARTICLE
Sheseira T L Struiken, Danique Lobée, Eline L van Tuinen, Daniel J Touw, Hester van der Vaart, Arno R Bourgonje, Bart L Rottier, Gerard H Koppelman, Paola Mian
Introduction: Patients with cystic fibrosis (CF) commonly experience pulmonary exacerbations, and it is recommended by the TOPIC study to treat this with tobramycin at a dose of 10 mg/kg once daily. The aim of this study was to evaluate the target attainment of the current dosing regimen. Methods: A single-center retrospective cohort study of child and adult patients with CF who received tobramycin between 2019 and 2022 was conducted. Descriptive statistics and linear mixed models were used to assess target attainment for tobramycin...
April 30, 2024: Journal of Clinical Medicine
keyword
keyword
13596
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.